# FDA Inspection 1200565 - Octapharma Plasma Inc - February 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6a1f188e-81ea-4e45-b27d-06ae1655d52a
Source feed: FDA_Inspections

> FDA Inspection 1200565 for Octapharma Plasma Inc on February 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1200565
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-02-17
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1200565 - 2023-02-17](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/b86dd732-0a7b-4d0b-89c8-ab5dc0997759)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/fe317630-2ce3-4d1d-84f0-ae59251721ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d